The News Wheel
No Comments

Mazda North America Takes Small April Sales Loss as Sedan Sales Plummet, Crossovers Rise

Decrease Font Size Increase Font Size Text Size Print This Page
Mazda has announced the redesigned CX-5 crossover will carry a starting MSRP of $24,045 for the 2017 model year

The 2017 Mazda CX-5 comes standard with LED headlights and Smart City Brake Support

Mazda has lately been concentrating on its crossovers (including designing a new one for Japan called the CX-8), and based on its North American sales in April, it was probably a good idea, because strongly rising crossover sales met sharply falling car sales coming the other way for a small overall sales loss.

Specifically, Mazda North America sold a total of 24,164 vehicles, a decrease of 7.8% compared to last April (although adjusted for the one fewer sales day in 2017, the daily sales rate is down only 4.2%).

Year-to-date sales are up, however, with 93,235 vehicles sold so far this year, an increase of 2.6% over last year.

The larger crossovers saw some of their best months yet—the CX-5, which went into a new generation last month, led sales with its best April of all time with 11,334 sold, a year-over-year increase of 28.4%. The three-row CX-9 had its best April since 2011, racking up 2,134 sales. Oddly, the compact CX-3 saw a sales decrease of 23.7% over last year, but the total sales of the brand’s three crossovers were up by a whopping 40.5% year-over-year, selling a total of 14,615 vehicles.

Mazda’s two car options, the compact Mazda3 and the full-size Mazda6, saw sales plummet compared to last April, with the Mazda3 dropping from 10,722 sales last year to 5,980 this year—a decrease of 44.2%. The Mazda6 barely fared better, with only 2,249 sales compared to last April’s 3,929 sales—a decrease of 42.8%

The MX-5 Miata, with both cloth-top and hardtop forms, did just fine in April, posting strong sales of 1,319 units sold, a year-over-year increase of 21.5%.

Mazda Motor de Mexico posted April sales of 3,830 vehicles, an increase of 5% year-over-year.